- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02514135
Intra-abdominal Hypertension in Critically Ill Patients
August 24, 2018 updated by: Patrick Murphy, Western University, Canada
The aim of the proposed study is to determine the incidence and prevalence of intra-abdominal hypertension and abdominal compartment syndrome in consecutive intensive care admissions using broad inclusion criteria.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Increased pressure within the abdominal cavity is particularly common in intensive care patients and has been shown to be an independent risk-factor for mortality in this patient population.
The quoted rates of intra-abdominal hypertension of range anywhere from 20-60% are dependent on the population of patient studied.
The prospective observational studies performed to date have been underpowered, used strict inclusion/exclusion criteria or were performed prior to consensus guidelines on the definition and measurement of intra-abdominal pressure and hypertension.
Study Type
Observational
Enrollment (Anticipated)
286
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6K 1C2
- Victoria Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All adults (>18 years of age) admitted to the intensive care unit at Victoria Hospital, London, Ontario who have a Foley catheter in-situ
Description
Inclusion Criteria:
- Foley catheter in-situ on admission
Exclusion Criteria:
- Contra-indication to bladder pressure measurement
- Home service asked that patient is not included
- Death within 24 priors of admission before bladder pressure measured
- No bladder pressure performed within 24 hours of admission
- Consent refused or unable to be obtained (lack of SDM, patient unable to provide)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Elevated Intra-abdominal Pressure
Patients with intra-abdominal pressure > 12 mmHg at any time throughout admission
|
|
|
Normal Intra-abdominal Pressure
Patients with intra-abdominal pressure < 12 mmHg throughout admission
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: While patient in-hospital, expected stay one week on average
|
As measured prospectively by patient death in the ICU
|
While patient in-hospital, expected stay one week on average
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay
Time Frame: While patient in-hospital, expected stay one week on average
|
Measured prospectively from date of admission to ICU to death, or discharge from ICU
|
While patient in-hospital, expected stay one week on average
|
|
Abdominal decompression
Time Frame: While patient in-hospital, expected stay one week on average
|
Midline laparotomy for abdominal compartment syndrome
|
While patient in-hospital, expected stay one week on average
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kelly N Vogt, MD, Western University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2015
Primary Completion (Actual)
January 30, 2016
Study Completion (Actual)
May 30, 2016
Study Registration Dates
First Submitted
July 30, 2015
First Submitted That Met QC Criteria
July 30, 2015
First Posted (Estimate)
August 3, 2015
Study Record Updates
Last Update Posted (Actual)
August 27, 2018
Last Update Submitted That Met QC Criteria
August 24, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WesternUCanada
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intra-Abdominal Hypertension
-
Dotspace Inc.Not yet recruitingIntra-Abdominal Hypertension | Intra Abdominal Pressure
-
Soroka University Medical CenterUnknownAbdominal Compartment Syndrome | Intra Abdominal Hypertension
-
Medical University of LublinEnrolling by invitationAbdominal Compartment Syndrome | Abdominal HypertensionPoland
-
Second Affiliated Hospital, School of Medicine,...CompletedIntra-Abdominal HypertensionChina
-
Makerere UniversityCompletedIntra-Abdominal HypertensionUganda
-
Tartu University HospitalUnknown
-
Chang Gung Memorial HospitalDOTSPACERecruiting
-
University of UtahCompletedIntra-Abdominal HypertensionUnited States
-
Nanjing Medical UniversityJinling Hospital, ChinaUnknownARDS | Intra-abdominal HypertensionSwitzerland
-
Tianjin Nankai HospitalNot yet recruitingIntra-abdominal Hypertension
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted